Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
170M
-
Number of holders
-
131
-
Total 13F shares, excl. options
-
56.5M
-
Shares change
-
+12.6M
-
Total reported value, excl. options
-
$1B
-
Value change
-
+$239M
-
Put/Call ratio
-
0.01
-
Number of buys
-
90
-
Number of sells
-
-43
-
Price
-
$17.75
Significant Holders of Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) as of Q4 2022
155 filings reported holding IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share as of Q4 2022.
Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) has 131 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 56.5M shares
of 170M outstanding shares and own 33.27% of the company stock.
Largest 10 shareholders include Deep Track Capital, LP (9.71M shares), VANGUARD GROUP INC (5.07M shares), BlackRock Inc. (3.93M shares), EVENTIDE ASSET MANAGEMENT, LLC (3.69M shares), Logos Global Management LP (3.15M shares), STATE STREET CORP (3.11M shares), BVF INC/IL (2.56M shares), FMR LLC (2.49M shares), Alpine Global Management, LLC (1.5M shares), and DIMENSIONAL FUND ADVISORS LP (1.3M shares).
This table shows the top 131 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.